Skip to main content
. 2021 Nov 2;13(12):e15098. doi: 10.15252/emmm.202115098

Figure 2. CSF p‐tau235 performance in the discovery cohort.

Figure 2

  1. Box‐and‐whiskers plot showing the levels of CSF p‐tau235 in neurological controls (n = 21) and biologically defined Alzheimer’s disease (AD) cases (n = 19).
  2. ROC analysis indicating the diagnostic accuracy of CSF p‐tau235 when discriminating AD from control.

Data information: Box‐and‐whisker plots show the median and the 25th and 75th percentiles. Group differences determined using Mann–Whitney U test (****P < 0.0001). All samples were run in singlicates.